REFERENCES
- Sigelman S, Friedenwald JS. Mitotic and wound-healing activities of the corneal epithelium: Effect of sensory denervation. AMA Arch Ophthalmol. 1954;52:46–57.
- Mittag TW, Mindel JS, Green JP. Trophic functions of the neuron. V. Familial dysautonomia: Choline acetyltransferase in familial dysautonomia. Ann N Y Acad Sci. 1974;228:301–306.
- Trabucchi, G., Brancato, R., Verdi, M., et al. Corneal nerve damage and regeneration after excimer laser photokeratectomy in rabbit eyes. Inves Ophthalmol Vis Sci. 1994;35:229–235.
- Linna TU, Vesaluoma MH, Pérez-Santonja JJ, et al. Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nerves. Invest Ophthalmol Vis Sci. 2000;41:393–397.
- Moilanen JA, Vesaluoma MH, Müller LJ, et al. Long-term corneal morphology after PRK by in vivo confocal microscopy. Invest Ophthalmol Vis Sci. 2003;44:1064–1069.
- Linna TU, Versaluoma MH, Perez-Santonja JJ, et al. Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nerves. Invest Ophthalmol Vis Sci. 2000;41:393–397.
- Wilson SE. Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy. Ophthalmology. 2001;108:1082–1087.
- Tessarollo L, Tsoulfas P, Martin-Zanca D, et al. TrkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues. Development. 1993;118:463–475.
- Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987;237:1154–1162.
- Riaz SS, Tomlinson DR. Neurotrophic factors in peripheral neuropathies: Pharmacological strategies. Prog Neurobiol. 1996;49:125–143.
- Mearow KM, Kril Y, Diamond J. Increased NGF mRNA expression in denervated rat skin. Neuroreport. 1993;4:351–354.
- Verge VM, Merlio JP, Grondin J, et al. Colocalization of NGF binding sites, trk mRNA, and low affinity NGF receptor mRNA in primary sensory neurons: Responses to injury and infusion of NGF. J Neurosci. 1992;12:4011–4022.
- Esquenazi S, Bazan HE, Bui V, et al. Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2005;46:3121–3127.
- Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. 1998;338:1174–1180.
- Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000;107:1347–1351.
- Saletu B, Paulus E, Linzmayer L, et al. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: A double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology (Berl). 1995;117:385–395.
- Herrmann WM, Stephan K, Gaede K, et al. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia. Dement Geriatr Cogn Disord. 1997;8:9–17.
- Nishio T, Sunohara N, Furukawa S, et al. Repeated injections of nicergoline increase the nerve growth factor level in the aged rat brain. Jpn J Pharmacol. 1998;76:321–323.
- Giardino L, Giuliani A, Battaglia A, et al. Neuroprotection and aging of the cholinergic system: A role for the ergoline derivative nicergoline (Sermion). Neuroscience. 2002;109:487–497.
- Kim SY, Choi JS, Joo CK. Effects of nicergoline on corneal epithelial wound healing in rat eyes. Invest Ophthalmol Vis Sci. 2009;50:621–625.
- Nishida T, Yanai R. Advances in treatment for neurotrophic keratopathy. Curr Opin Ophthalmol. 2009;20:276–281.
- Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992;49:693–698.
- Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. Arch Ophthalmol. 1997;115:926–927.
- Tripathi BJ, Kwait PS, Tripathi RC. Corneal growth factors: A new generation of ophthalmic pharmaceuticals. Cornea. 1990;9:2–9.
- Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111:1115–1120.